|
1
|
Ishiyama H, Satoh T, Kawakami S, Tsumura
H, Komori S, Tabata K, Sekiguchi A, Takahashi R, Soda I, Takenaka
K, et al: A prospective quasi-randomized comparison of
intraoperatively built custom-linked seeds versus loose seeds for
prostate brachytherapy. Int J Radiat Oncol Biol Phys. 90:134–139.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Twyman-Saint Victor C, Rech AJ, Maity A,
Rengan R, Pauken KE, Stelekati E, Benci JL, Xu B, Dada H, Odorizzi
PM, et al: Radiation and dual checkpoint blockade activate
non-redundant immune mechanisms in cancer. Nature. 520:373–377.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nesslinger NJ, Sahota RA, Stone B, Johnson
K, Chima N, King C, Rasmussen D, Bishop D, Rennie PS, Gleave M, et
al: Standard treatments induce antigen-specific immune responses in
prostate cancer. Clin Cancer Res. 13:1493–1502. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schaue D, Comin-Anduix B, Ribas A, Zhang
L, Goodglick L, Sayre JW, Debucquoy A, Haustermans K and McBride
WH: T-cell responses to survivin in cancer patients undergoing
radiation therapy. Clin Cancer Res. 14:4883–4890. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takeshima T, Chamoto K, Wakita D, Ohkuri
T, Togashi Y, Shirato H, Kitamura H and Nishimura T: Local
radiation therapy inhibits tumor growth through the generation of
tumor-specific CTL: Its potentiation by combination with Th1 cell
therapy. Cancer Res. 70:2697–2706. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ma Y, Kepp O, Ghiringhelli F, Apetoh L,
Aymeric L, Locher C, Tesniere A, Martins I, Ly A, Haynes NM, et al:
Chemotherapy and radiotherapy: Cryptic anticancer vaccines. Semin
Immunol. 22:113–124. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gameiro SR, Jammeh ML, Wattenberg MM,
Tsang KY, Ferrone S and Hodge JW: Radiation-induced immunogenic
modulation of tumor enhances antigen processing and calreticulin
exposure, resulting in enhanced T-cell killing. Oncotarget.
5:403–416. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stone HB, Peters LJ and Milas L: Effect of
host immune capability on radiocurability and subsequent
transplantability of a murine fibrosarcoma. J Natl Cancer Inst.
63:1229–1235. 1979.PubMed/NCBI
|
|
9
|
Yoshimoto Y, Suzuki Y, Mimura K, Ando K,
Oike T, Sato H, Okonogi N, Maruyama T, Izawa S, Noda SE, et al:
Radiotherapy-induced anti-tumor immunity contributes to the
therapeutic efficacy of irradiation and can be augmented by CTLA-4
blockade in a mouse model. PLoS One. 9:e925722014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ludgate CM: Optimizing cancer treatments
to induce an acute immune response: Radiation abscopal effects,
PAMPs, and DAMPs. Clin Cancer Res. 18:4522–4525. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marabelle A, Filatenkov A, Sagiv-Barfi I
and Kohrt H: Radiotherapy and toll-like receptor agonists. Semin
Radiat Oncol. 25:34–39. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fernández-García EM, Vera-Badillo FE,
Perez-Valderrama B, Matos-Pita AS and Duran I: Immunotherapy in
prostate cancer: Review of the current evidence. Clin Transl Oncol.
17:339–357. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kachikwu EL, Iwamoto KS, Liao YP, DeMarco
JJ, Agazaryan N, Economou JS, McBride WH and Schaue D: Radiation
enhances regulatory T cell representation. Int J Radiat Oncol Biol
Phys. 81:1128–1135. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu CT, Chen MF, Chen WC and Hsieh CC: The
role of IL-6 in the radiation response of prostate cancer. Radiat
Oncol. 8:159–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu J, Escamilla J, Mok S, David J,
Priceman S, West B, Bollag G, McBride W and Wu L: CSF1R signaling
blockade stanches tumor-infiltrating myeloid cells and improves the
efficacy of radiotherapy in prostate cancer. Cancer Res.
73:2782–2794. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tabi Z, Spary LK, Coleman S, Clayton A,
Mason MD and Staffurth J: Resistance of CD45RA- T cells to
apoptosis and functional impairment, and activation of
tumor-antigen specific T cells during radiation therapy of prostate
cancer. J Immunol. 185:1330–1339. 2010. View Article : Google Scholar : PubMed/NCBI
|
